| Literature DB >> 28753972 |
Haifeng Li1,2, Fei Ding3, Lingyun Xiao4, Ruona Shi5, Hongyu Wang6, Wenjing Han7, Zebo Huang8.
Abstract
Oxidative stress is known to impair architecture and function of cells, which may lead to various chronic diseases, and therefore therapeutic and nutritional interventions to reduce oxidative damages represent a viable strategy in the amelioration of oxidative stress-related disorders, including neurodegenerative diseases. Over the past decade, a variety of natural polysaccharides from functional and medicinal foods have attracted great interest due to their antioxidant functions such as scavenging free radicals and reducing oxidative damages. Interestingly, these antioxidant polysaccharides are also found to attenuate neuronal damages and alleviate cognitive and motor decline in a range of neurodegenerative models. It has recently been established that the neuroprotective mechanisms of polysaccharides are related to oxidative stress-related pathways, including mitochondrial function, antioxidant defense system and pathogenic protein aggregation. Here, we first summarize the current status of antioxidant function of food-derived polysaccharides and then attempt to appraise their anti-neurodegeneration activities.Entities:
Keywords: antioxidant; inflammatory stress; neurodegeneration; oxidative stress; polysaccharide; proteotoxic stress
Mesh:
Substances:
Year: 2017 PMID: 28753972 PMCID: PMC5537892 DOI: 10.3390/nu9070778
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
The antioxidant activities and mechanisms of food-derived polysaccharides.
| Source | Polysaccharide | Test Model | Protective Effect | Potential Mechanism | Ref. |
|---|---|---|---|---|---|
| ZLPs-W | In vitro assays | Scavenging activity against DPPH and ·OH | [ | ||
| CWSP | In vitro assays | Scavenging activity against DPPH, reducing power, prevention of β-carotene bleaching | Ferrous chelating ability | [ | |
| WSP | In vitro assays | Scavenging activity against DPPH, inhibition of ascorbic acid oxidation | SOD-like activity | [ | |
| PPPWs | In vitro assays | Scavenging activity against DPPH and ABTS, reducing power, total antioxidant capacity | [ | ||
| PAP | H2O2-exposed murine splenic lymphocytes | Apoptosis rate↓ | [ | ||
| PS-PGL | In vitro assays; H2O2-exposed Vero cells and zebrafish | Scavenging activity against DPPH, ·OH and alkyl radicals in vitro; Cell viability↑, DNA fragmentation↓, nuclear condensation and morphological disruption↓ in Vero cells; Survival↑, heart-beating rate↓, cell death↓ in zebrafish embryos | ROS level↓ in Vero cells; ROS level↓, MDA content↓ in zebrafish embryos | [ | |
| APPS | In vitro assays | Scavenging activity against DPPH, O2−· and ·OH, reducing power | [ | ||
| PFP | In vitro assays | Scavenging activity against DPPH, O2−· and ·OH, reducing power | [ | ||
| Seed watermelon | SWP | H2O2-exposed PC12 cells | Cell viability↑, LDH release↓ | ROS level↓, 8-OHdG content↓, caspase-3 and caspase-9 activities↓, MMP↑ | [ |
| Rice bran | RBP2 | In vitro assays | Scavenging activity against DPPH, O2−·, ·OH and ABTS, reducing power | Ferrous chelating ability | [ |
| Wheat bran | Feruloyl oligosaccharides | AAPH-exposed human erythrocytes | Erythrocyte hemolysis↓ | GSH level↓, MDA content↓, PCG level↓ | [ |
| MSF | In vitro assays | Scavenging activity against ABTS, reducing power | [ | ||
| CHPS | In vitro assays; H2O2-exposed PC12 cells | Scavenging activity against ABTS, DPPH O2−; reducing power in vitro; Cell viability↑ | [ | ||
| Yam polysaccharide | In vitro assays | Scavenging activity against O2−· and ·OH | [ | ||
| EbPS-A1 | In vitro assays; PQ-exposed | Scavenging activity against DPPH and ·OH in vitro; Survival rate↑ in | ROS level↓, MDA content↓, SOD and CAT activities↑ in | [ | |
| CVPS | In vitro assays; | Scavenging activity against DPPH, O2−· and ·OH in vitro; Body weights and spleen indices↑ in mice | Activities and mRNA levels of Mn-SOD, Cu/Zn-SOD, GPx and CAT↑, MDA content↓ in mouse liver, heart and brain | [ | |
| RRPs | UV-irradiated mice | GSH level↑, SOD, CAT and GPx activities↑, MDA content↓, IL-2, IL-4 and IL-10 levels↑ | [ | ||
| LBPs | H2O2-exposed SRA01/04 cells | Cell viability↑, apoptotic rate↓, ratio of ageing cells↓, G0/G1 cell cycle phase arrest↓ | ROS level↓, MMP↑, Bcl-2 protein level↑, Bax protein level↓, MDA content↓, SOD activity↑, GSH level↑ | [ | |
| ASP | H2O2-exposed PC12 cells; SD rats with middle cerebral artery occlusion | Cell viability↑, apoptosis rate↓ in PC12 cells; Number of microvessels in rat brain↑ | ROS level↓, MMP↑ in PC12 cells; SOD and GPx activities↑ in rat cortex | [ | |
| SSP | PCV-2 infection RAW264.7 cells | Activities of Total-SOD, Cu/Zn-SOD and Mn-SOD↑, mRNA levels of Mn-SOD↑ and NOX2↓, NOX2 protein level↓, MMP↑ | [ | ||
| CSP | H2O2-exposed PC12 cells | Cell viability↑, ratio of sub G1and S phase↓, ratio of G2/M phase↑, apoptosis rate↓, LDH release↓ | ROS level↓,MDA content↓, 8-OHdG content↓, SOD and GPx activities↑, capase-3 and capase-9 activities↓ | [ | |
| Black tea | BTPS | In vitro assays | Scavenging activity against DPPH and ·OH | [ | |
| Green tea | TPS1 | In vitro assays | Scavenging activity against DPPH, O2−· and ·OH, ferrous chelating ability, reducing power, total antioxidant capacity, inhibition of lipid hydroperoxide | [ | |
| GPMMP | Cyclophosphamide-treated C57BL/6 mice | Spleen and thymus indices↑, CD4+ T lymphocyte counts↑, total antioxidant capacity↑ | CAT, SOD and GPx activities↑, MDA content↓, GSH level↑, IL-2 level in sera and spleen↑ | [ | |
| SJP | In vitro assays | Scavenging activity against DPPH, ·OH and ABTS, reducing power | [ | ||
| GNP | In vitro assays; Hyperlipemia mice | Scavenging activity against DPPH, O2−· and ·OH in vitro | CAT, SOD and GPx activities↑, MDA content↓ in mouse serum and liver | [ | |
| Other Plants | |||||
| ZJPa | In vitro assays | Scavenging activity against O2−· and ·OH | Ferrous chelating ability | [ | |
| GAPS-1 and SAPS-1 | In vitro assays | Scavenging activity against O2−·, ·OH and H2O2, reducing power, MDA content↓ | Ferrous chelating ability | [ | |
| ARPT | CCl4-treated Kunming mice | Hepatocyte necrosis↓, serum alanine transaminase and aspartate transaminase activities↓ | MDA level↓, SOD, CAT and GPx activities↑, GSH level↓, mRNA levels of TNF-α, IL-6 and Bax↓, protein levels of TNF-α, IL-6, NF-κB and cleaved-caspase 3↓ in liver | [ | |
| CP | H2O2-exposed PC12 cells | Cell viability↑, LDH release↓, apoptosis rate↓ | ROS level↓, ratio of Bax/Bcl-2 mRNA level↑ | [ | |
| SCP1 | In vitro assays; PQ-exposed | Scavenging activity against O2−· and ·OH in vitro; Survival rate↑ in | Ferric chelating ability in vitro; SOD, CAT and GPx activities↑, MDA content↓ in | [ | |
| TOP2 | LPS or | NO production↓ in LPS-exposed cells; Cell viability↑ in | Protein levels of TNF-α, p-IκBα, p-p65, p-Akt, iNOS and heme oxygenase 1↓ | [ | |
| Isoproterenol-treated albino rats | Creatinine kinase and LDH activities↓ in serum, cardiac muscle fibers with mild hyalinization | ROS level↓, MDA content↓, SOD and GPx activities↑, GSH level↑, activities of Krebs cycle dehydrogenases and mitochondrial complexes↑, MMP↑ | [ | ||
| Mushroom polysaccharides | In vitro assays | Scavenging activity against DPPH, reducing power, inhibition of linoleic acid peroxidation | Ferric chelating ability | [ | |
| DiPS | PQ-exposed | Survival rate↑ | ROS level↓, SOD activity↑, MDA content↓, MMP↑, ATP content↑, DAF-16 activation↑ | [ | |
| AAP1 | In vitro assays; PQ or H2O2-exposed | Scavenging activity against DPPH, O2−· and ·OH, reducing power in vitro; Survival rate↑ in | Ferric chelating ability in vitro; ROS level↓, SOD and CAT activities↑ in | [ | |
| TP | UV-irradiated SD rats | Water and collagen content↑, glycosaminoglycan↓, endogenous collagen breakdown↓, ratio of type I/III collagen↑ in rat skin | SOD, GPx and CAT activities↑ | [ | |
| In vitro assays; H2O2-exposed rat erythrocytes and liver microsome | Scavenging activity against O2−· and ·OH in vitro; Erythrocyte hemolysis↓; lipid peroxidation of rat liver microsome↓ | [ | |||
| LJPA-P3 | In vitro assays | Oxygen radical absorbance capacity, scavenging activity against ABTS | [ | ||
| In vitro assays | Ferric reducing antioxidant power | [ | |||
| In vitro assays | Scavenging activity against O2−· and ·OH, reducing power | Ferric chelating ability | [ | ||
| Brown seaweed | Fucoidan | UV-irradiated HS68 cells | ROS level↓, MDA content↓, GSH level↑ | [ | |
| In vitro assays; PQ-exposed | Scavenging activity against O2−· and ·OH in vitro; Survival rate↑ in | SOD, CAT and GPx activities↑, MDA content↓ in | [ | ||
| Milk fermented with lactic acid bacteria | Exopolysaccharides | UV-irradiated hairless mice | Erythema formation, dryness and epidermal proliferation, cyclobutane pyrimidine dimers↓ in mouse skin | mRNA levels of xeroderma pigmentosum complementation group A↑, ratio of mRNA levels of IL10/IL12α and IL10/IFN-γ↓ in mouse skin | [ |
| Red wine | PS-SI | In vitro assays | Scavenging activity against ·OH, oxygen radical absorbance capacity | [ | |
| EPS | In vitro assays; | Inhibition of linoleic acid peroxidation, total antioxidant capacity, scavenging activity against DPPH, O2−· and ·OH in vitro | Total antioxidant capacity, SOD, CAT and GPx activities↑, MDA content↓ in serum, GST activity and MDA content↓ in liver, MAO activity and lipofuscin level↓ in brain | [ | |
| B-EPS and L-EPS | In vitro assays; H2O2-exposed rat erythrocytes | Scavenging activity against DPPH, O2−· and ·OH, inhibition of lipid peroxidation in vitro; Erythrocyte hemolysis↓ | [ | ||
| ASP-1 | In vitro assays | Scavenging activity against O2−· | [ | ||
| CHPs | In vitro assays | Scavenging activity against DPPH, ·OH and ABTS, inhibition of linoleic acid peroxidation | [ | ||
| MP-I | CCl4-treated Kunming mice | Serum alanine transaminase and aspartate transaminase levels↓, necrosis of liver cells↓, immigration of inflammatory cells↓ | MDA content↓, SOD activity↑ in liver | [ |
AAPH, 2,2′-Azobis(2-amidinopropane) dihydrochloride; ABTS, 2,2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid); CAT, catalase; CCl4, carbon tetrachloride; Cu/Zn-SOD, copper-zinc superoxide dismutase; d-Gal, d-galactose; DPPH, 2,2-diphenyl-1-picrylhydrazyl radical; GPx, glutathione peroxidase; GSH, glutathione; GST, glutathione S-transferase; H2O2, hydrogen peroxide; HS68 cells, human foreskin fibroblast line; IFN-γ, interferon-γ; IκBα, NF-κB inhibitor α; ILs, interleukins; iNOS, inducible nitric oxide synthase; LDH, lactate dehydrogenases; LPS, lipopolysaccharide; MAO, monoamine oxidase; MDA, malondialdehyde; MMP, mitochondrial membrane potential; Mn-SOD, manganese superoxide dismutase; NF-κB, nuclear factor-κB; NO, nitric oxide; NOX2, cytochrome b-245β chain; O2−·, superoxide anion; ·OH, hydroxyl radical; RAW 264.7 cells, murine macrophage cell line; PC12 cells, rat pheochromocytoma cell line; PCG, protein carbonyl group; PCV-2, porcine circovirus type 2; PQ, paraquat; ROS, reactive oxygen species; SOD, superoxide dismutase; SRA01/04 cells, SV40 T-antigen-transformed human lens epithelial cell line; t-BHP, tert-Butyl hydroperoxide; TNF-α, tumor necrosis factor α; UV, ultraviolet; 8-OHdG, 8-hydroxy-2’-deoxyguanosine.
Protective effects and mechanisms of food-derived antioxidant polysaccharides in neurodegeneration models.
| Source | Polysaccharide | Test Model | Protective Effect | Potential Mechanism | Ref. |
|---|---|---|---|---|---|
| GLP | APP/PS1 transgenic mice | Learning and memory in MWM↑, neural progenitor cell proliferation↑ | Aβ deposits↓, protein levels of p-FGFR1, p-ERK and p-Akt↑ | [ | |
| Marine red algae | KCP | Aβ(25–35)-exposed SH-SY5Y cells | Cell viability↑, apoptosis rate↓ | Protein level of cleavage caspase 3↓, JNK signaling activation↓ | [ |
| Fucoidan | Aβ(25–35) and | Cell viability↑, apoptosis rate↓ in PC12 cells; Learning and memory in MWM↑ | Protein levels of cleaved caspase-3, caspase-8 and caspase-9↓, cytochrome c release↓, SOD activity↑, GSH level↑ in PC12 cells; Aβ deposits in hippocampus↓, SOD activity and GSH level↑ in serum, Ach content↑, ChAT activity↑ and AChE activity↓ in brain | [ | |
| Fucoidan | Aβ40-treated SD rats | Learning and memory in MWM, single-trial passive avoidance and eight-arm radial maze task↑ | Ach content↑, ChAT activity↑, AChE activity↓, SOD and GPx activities↑, MDA content↓, Bax/Bcl-2 protein level ratio↓, cleaved caspase-3 protein level↓ in hippocampus | [ | |
| PS-WNP | Aβ(25–35)-exposed PC12 cells | Cell viability↑, apoptosis rate↓ | Bax/Bcl-2 protein level ratio↓, MMP↑, cytochrome c release↓, cleaved caspase-3 protein level↓, caspase-3 activity↓, p-Akt protein level↑ | [ | |
| LJW0F2 | Aβ42-exposed SH-SY5Y cells | Cell viability↑ | Aβ42 aggregates↓ | [ | |
| AOSC | Aβ(25–35)-exposed SH-SY5Y cells | Cell viability↑, apoptosis rate↓, activation of astrocytes↓, cell redox activity↑ | ROS level↓, TNF-α and IL-6 level↓, calcium influx in astrocytes↓ | [ | |
| AS | Aβ(25–35)-exposed Neuro 2A cells | Cell viability↑ | ROS level↓, GSH level↑, MMP↑, mitochondria mass↑, TBARS content↓, autophagosomes or residual bodies↓ | [ | |
| APP/PS1 transgenic mice | Learning and memory in MWM↑ | Aβ deposits in hippocampus↓ | [ | ||
| LBP-III | Aβ(25–35)-exposed rat primary cortical neurons | Maintain neurite fasciculation and neuron integrity | Caspase-3 and caspase-2 activities↓, p-PKR protein level↓ | [ | |
| GLA | Aβ(25–35)- or Aβ42-exposed rat primary cortical neurons | Apoptosis rate↓, synaptophysin immunoreactivity↑ | DEVD-cleavage activity↓, protein levels of p-JNK, p-c-Jun, and p-p38↓ | [ | |
| PS5 | T-REx293 cells | Cell viability↑ | Aβ42-EGFP aggregates↓ | [ | |
| DiPS | Survival rate↑, chemotaxis index↑ | ROS level↓ | [ | ||
| GPP1 | Aβ(25–35)-exposed PC12 cells | Cell viability↑, LDH release↓, DNA fragmentation↓ | ROS level↓, MDA content↓, SOD activity↑, GSH level↑, Calcium overload↓, MMP↑, Bcl-2 protein level↑, protein levels of Bax, cytochrome c and cleaved caspase-3↓ | [ | |
| LBP | 6-OHDA-exposed PC12 cells | Cell viability↑, nuclear morphology changes↓, apoptosis rate↓ | ROS and NO levels↓, calcium overload↓, protein-bound 3-nitrotyrosine level↓, protein levels of nNOS, iNOS and cleaved caspase-3↓ | [ | |
| GP | MPP+-exposed PC12 cells | Cell viability↑, LDH release↓, apoptosis rate↓ | Cytochrome c release↓, caspase-3 and caspase-9 activities↓, Bax/Bcl-2 protein level ratio↓, protein levels of cleaved caspase-3 and poly (ADP-ribose) polymerase↓ | [ | |
| PSP | MPTP-treated C57BL/6J mice | Number of TH-immunoreactive neurons and DAT binding ratio in the substantia nigra pars compacta↑ | TH and DAT mRNA levels in substantia nigra↑, SOD and GPx activity↑ in serum and midbrain | [ | |
| CPS | MPTP-treated C57BL/6J mice | Body weight↑, movement in pole test and gait test↑ | Contents of DA, DOPAC and HVA↑, ratio of DOPAC and HVA to DA↓, TH mRNA level↑, striatal Emr1 mRNA level↓, TNF-α, IL-1β and IL-6 levels in serum↓, | [ | |
| SA-Gc | 6-OHDA-treated Wistar rats | Locomotor performance in OFT, rotarod and apomorphine-induced rotation test↑, weight gain↑ | DA and DOPAC content↑, NO2/NO3 and GSH level↑ in brain, p65, iNOS and IL1β mRNA levels↓, BDNF mRNA level↑ | [ | |
| SJP | 6-OHDA-exposed SH-SY5Y cells | Cell viability↑, apoptosis rate↓, LDH release↓ | SOD activity↑, ROS level↓, NO release↓, MDA content↓, MMP↑, cytochrome c release↓, percentage of cells in S phase↑, Bax/Bcl-2 protein level ratio↓, protein levels of Cyclin D3, p-p53, p-p38, p-JNK1/2, p-p65, iNOS and p-IκB↓, cleaved caspase-9/caspase-9 and cleaved caspase-3/caspase-3 protein level ratio↓, p-Akt and IκB protein levels↑ | [ | |
| EA | MPTP-treated C57BL/6 mice | Apoptosis rate↓, number of normal neurons↑, motor function in RT↑ | Nitro-tyrosine and 4-HNE level↓, dopamine, NGF, and GSH level↑, protein levels of Fas, p-JNK1/2, p-p38, DNA damage inducible transcript 3, NF-κB and p65↓ | [ | |
| EbPS-A1 | Avoidance index↑ | ROS level↓, MDA content↓, SOD and CAT activities↑ | [ | ||
| TD fucoidan | MPTP-treated C57BL/6 mice | Motor performance in OFT, Narrow beam walking and RT↑, nigral TH immunoreactivity↑ | DA, DOPAC, and HVA content↑, TBARS level↓, GSH level↑, SOD and CAT activities↓, GPx activity↑, TH and DAT protein levels↑ | [ | |
| LBP | HEK293-160Q cells; HD-related transgenic mice | Cell viability↑ in HEK293 cells; Survival rate↑, weight gain↑, motor performance in RT↑ in mice | Soluble and aggregated huntingtin levels↓, caspase-3 activity↓, p-Akt/Akt and p-GSK3β/ GSK3β protein levels↑ in HEK293 cells; Mutant huntingtin level↓, p-Akt/Akt and p-GSK3β/ GSK3β protein levels↑ in mouse brain | [ | |
| GLP | Kainic acid-treated Wistar rats | Frequency of epilepsy↓ | CaMK II level↑, ERK1/2 level↓, calcium turnover↓, Caveolin-1 positive cells↑, NF-κB positive cells↓ | [ | |
| HE | Differentiation rate↑, cell viability↑, apoptosis rate↓ in PC12 cells; learning, memory and locomotor in MWM, Autonomic activities and RT↑ | β-tubulin III protein level↑, MMP↑, calcium overload↓, ROS level↓ in PC12 cells; Ach and ChAT contents in mouse serum and hypothalamus↑ | [ | ||
| POP | Learning and memory in MWM and SDT↑, hippocampal impairment↓ | AchE activity↓, in hippocampus, MDA content↓, SOD, GPx and CAT activities↑ in hippocampus, liver and serum, protein levels of APP, Aβ, BACE1 and p-tau↓, Protein phosphatase 2 protein level↑ | [ | ||
| SFPS65A | SCO-, ethanol- and sodium nitrite-treated ICR mice | Learning and memory in SDT↑ | [ | ||
| SFPS | CAT and SOD activities↑, MDA content in hearts and MAO in brains↓, protein levels of Nrf2, Bcl-2, p21 and JNK1/2↑, mRNA levels of Nrf2, Cu/Zn-SOD, Mn-SOD, glutamate cysteine ligase and GPX1↑, voltage dependent anion channel 1 protein level↓ | [ | |||
| LBA | Homocysteine-exposed cortical neurons | Cell viability↑, apoptosis rate↓ | LDH release and caspase-3 activity↓, p-tau-1 protein level↑, cleaved-tau protein level↓, p-ERK1/2 and p-JNK protein levels↓ | [ | |
| LBA | Cell viability↑, maintained their integrity and fasciculation of neurites | LDH release and caspase-3 activity↓, p-JNK-1/JNK protein level ratio↓ | [ | ||
| β-glucan | SCO-treated SD rats | Learning, memory, and locomotor in MWM and PTT↑ | AChE activity↓ | [ | |
| FVP | SCO-treated Wistar rats | Learning and memory in MWM and PTT↑ | SOD and GPx activities↑, TBARS level↓, Ach, 5-HT, DA and NE content↑, ChAT activity↑, AChE activity↓, connexin 36 and p-CaMK II protein level↑ in hippocampus and cerebral cortex | [ | |
| LBPs | SCO-treated SD rats | Learning and memory in MWM, NOR and OLR↑, cell proliferation and neuroblast differentiation in dentate gyrus↑ | SOD and GPX activities↑, MDA content↓, Bax/Bcl-2 protein level ratio↓ in hippocampus | [ | |
| LBP | Weight gain↑, learning and memory in Jumping test↑, thymus and spleen indices↑ | Lipid peroxidation, lipofuscin and MAO-B contents↓ in brain | [ | ||
| PSP | SCO-treated Kunming mice | Learning and memory in SDT and Memory test↑ | SOD and GPx activities↑, MDA content↓ | [ | |
| WGOS | SCO-treated ICR mice | Learning and memory in MWM and NOR↑ | mRNA levels of GFAP, IL-1β and IL-6↓ in hippocampus, number of GFAP-positive cells↓ in hippocampal subregions | [ | |
| LT2 | Erythrocyte membrane fluidity↑ | SOD and GPx activities↑ in liver, heart and brain | [ | ||
| ASP | Percentage of ageing cells↓ | Advanced glycation end-product level in serum↓, ROS level↓, TAOC content↑, 8-OHDG content↓, 4-HNE level↓, protein levels of H2A histone family member X, p16, p21, p53, β-catenin, p-GSK-3β and transcription factor 4↓, mRNA levels of p16, p21 and β-catenin↓, GSK-3β protein level↑ | [ | ||
| TLH-3 | Cell viability↑, percentage of ageing cells↓, ratio of G0/G1phase↓, nucleic morphological changes↓ in HELF cells | ROS level↓, in HELF cells; SOD and CAT activities↑, MDA content↓, in mouse liver and serum | [ | ||
| PCCL | Apoptosis rate of cardiomyoctyes↓ | Calcium overload↓, Bax/Bcl-2 protein level ratio↓, caspase-3 activity↓, cytochrome c release↓ | [ | ||
| PSG-1 | Weight gain↑, lymphocyte proliferation↑ | MDA content↓, SOD, CAT and GPx activities↑, GSH level↑, GSSG level↓ in liver, brain and spleen | [ | ||
| APP 1-a | Spleen and thymus indexes↑ | MDA content↓, SOD and GPx activities↑ in liver, serum and heart | [ | ||
| DJ0.5 | 6-OHDA-exposed MES 23.5 cells and SH-SY5Y cells | Cell viability↑ | [ |
Aβ, amyloid-β peptide; Ach, acetylcholine; AChE, acetylcholinesterase; APP, amyloid precursor protein; BACE1, β-secretase 1; BDNF, brain-derived neurotrophic factor; CaMK II, calmodulin-dependent protein kinase II; CAT, catalase; ChAT, choline acetyltransferase; CL2355, a nematode that pan-neuronally expresses Aβ42; Cu/Zn-SOD, copper-zinc superoxide dismutase; d-Gal, d-galactose; DA, dopamine; DAT, dopamine transporter; DOPAC, 3,4-Dihydroxyphenylacetic acid; FGFR1, fibroblast growth factor receptor 1; GFAP, glial fibrillary acid protein; GPx, glutathione peroxidase; GSH, glutathione; GSK-3β, glycogen synthase kinase-3β; GSSG, glutathione disulfide; HA759, a nematode that expresses HtnQ150 in ASH neurons; HEK293 cells, human embryonic kidney cell line; HELF cells, human embryonic lung fibroblast line; HVA, homovanillic acid; IκB, NF-κB inhibitor; iNOS, inducible nitric oxide synthase; LDH, lactate dehydrogenases; l-Glu, l-glutamate; MAO, monoamine oxidase; MES 23.5 cells, rodent mesencephalic neuronal cell line; MDA, malondialdehyde; MMP, mitochondrial membrane potential; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; MPP+, 1-methyl-4-phenylpyridinium; MWM, Morris water maze; NE, norepinephrine; Neuro 2A cells, murine neuroblastoma cell line; NMDA, N-methyl-d-aspartate; nNOS, neuronal nitric oxide synthase; NO, nitric oxide; NOR, novel object recognition; Nrf2, nuclear factor erythroid 2-related factor 2; OLR, object location recognition; OFT, open field test; PC12 cells, rat pheochromocytoma cell line; PS1, presenilin-1; PTT, probe trial test; ROS, reactive oxygen species; RT, Rotarod test; SCO, scopolamine; SDT, step-down test; SH-SY5Y, human neuroblastoma cell line; SOD, superoxide dismutase; TAOC, total antioxidant capacity; TBARS, thiobarbituric acid reactive substances; TH, tyrosine hydroxylase; TNF-α, tumor necrosis factor α; T-REx293, human embryonic kidney cell line transiently transfected with Aβ42-EGFP; t-BHP, tert-butylhydroperoxide; 4-HNE, 4-hydroxynonenal; 5-HT, 5-hydroxytryptamine; 6-OHDA, 6-hydroxydopamine; 8-OHDG, 8-hydroxydeoxyguanosine.
Figure 1Pharmacological intervention of neurodegeneration by food-derived antioxidant polysaccharides. A number of extrinsic and intrinsic stresses such as proteotoxic stress, inflammatory stress and chemical interruption can stimulate oxidative stress through impairing the function of antioxidant system and mitochondria. Increase of oxidative stress can promote pathogenic protein aggregation and inflammation, eventually leading to neuronal injury, death and dysfunction via multiple biochemical pathways (solid line). However, food-derived antioxidant polysaccharides can exert beneficial effects to suppress neurodegeneration via attenuating oxidative, inflammatory and proteotoxic stresses and regulating stress-related signaling (dashed line).